XCUR Stock Analysis: Buy, Sell, or Hold?
XCUR - Exicure, Inc. Common Stock
$2.58
-0.11 (-4.09%)
▼
5d:
+20.0%
30d:
-3.5%
90d:
-44.03%
BUY
HIGH Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Jun 26, 2026
TODAY
Get Alerted When XCUR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: XCUR shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: XCUR shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: XCUR is currently trading at $2.58, which is considered slightly low relative to its 30-day fair value range of $2.54 to $3.09.
Technical Outlook: Technically, XCUR is in a downtrend. The price is currently testing key support at $2.62. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: XCUR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $2.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XCUR is in a downtrend. The price is currently testing key support at $2.62. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: XCUR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $2.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.54 -
$3.09
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.1%)
- BEARISH: Trading 25.7% above Wall St target ($2.00)
Trading Range Analysis
30-Day Trading Range
$2.54 -
$3.09
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.62
Resistance Level
$3.45
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$2.00
(-25.7%)
Revenue Growth (YoY)
928.0%
Share & Embed Analysis
Last updated: June 25, 2026 1:41 PM ET
Data refreshes hourly during market hours. Next update: 2:41 PM
Data refreshes hourly during market hours. Next update: 2:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XCUR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 53 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 61 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 58 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 61 BUY |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 58 HOLD |